Extended-release quetiapine versus immediate-release quetiapine in older Alzheimer's disease patients with symptoms of agitation and/or psychosis

Trial Profile

Extended-release quetiapine versus immediate-release quetiapine in older Alzheimer's disease patients with symptoms of agitation and/or psychosis

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Mar 2012

At a glance

  • Drugs Quetiapine (Primary)
  • Indications Agitation; Alzheimer's disease; Psychotic disorders
  • Focus Adverse reactions
  • Most Recent Events

    • 01 Mar 2012 Results published in the International Journal of Geriatric Psychiatry.
    • 14 Feb 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top